Cargando...
Defining a New Role for the National Cancer Institute Cooperative Groups: More Science, Fewer Trials
In the context of major changes, it is likely that the National Cancer Institute’s Cooperative Groups will not have the resources to perform many of the traditional, definitive, randomized phase III trials of the past; industry will have to play a greater role in refining drug sequences or combinati...
Guardado en:
| Publicado en: | Oncologist |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AlphaMed Press
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221382/ https://ncbi.nlm.nih.gov/pubmed/25326160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0359 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|